Hello,

We noticed you're browsing in private or incognito mode.

To continue reading this article, please exit incognito mode or log in.

Not an Insider? Subscribe now for unlimited access to online articles.

A View from

Biological Engineer Shiladitya Sengupta on Using Technology To Solve Medical Problems

  • August 17, 2006

In our ongoing project to catch up with last year’s TR35, we sat down with Shiladitya Sengupta, now an assistant professor in the Harvard-MIT Division of Health Sciences and Technology. He talked with us about how the “nanocell” cancer treatment technology that initially drew him to our attention fits in with his philosophy of using technology to solve medical problems for everyone–not just the elite. Sengupta’s passion for applying basic science to the creation of medicines that patients can actually use is unmistakable.

Want more award-winning journalism? Subscribe to Insider Plus.
  • Insider Plus {! insider.prices.plus !}*

    {! insider.display.menuOptionsLabel !}

    Everything included in Insider Basic, plus the digital magazine, extensive archive, ad-free web experience, and discounts to partner offerings and MIT Technology Review events.

    See details+

    Print + Digital Magazine (6 bi-monthly issues)

    Unlimited online access including all articles, multimedia, and more

    The Download newsletter with top tech stories delivered daily to your inbox

    Technology Review PDF magazine archive, including articles, images, and covers dating back to 1899

    10% Discount to MIT Technology Review events and MIT Press

    Ad-free website experience

/3
You've read of three free articles this month. for unlimited online access. You've read of three free articles this month. for unlimited online access. This is your last free article this month. for unlimited online access. You've read all your free articles this month. for unlimited online access. You've read of three free articles this month. for more, or for unlimited online access. for two more free articles, or for unlimited online access.